2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: Developed by the task force for the …
K Zeppenfeld, J Tfelt-Hansen, M De Riva… - European heart …, 2022 - academic.oup.com
4004 ESC Guidelines label use of medication should be limited to situations where it is in
the patient's interest to do so, with regard to the quality, safety, and efficacy of care, and only …
the patient's interest to do so, with regard to the quality, safety, and efficacy of care, and only …
[HTML][HTML] Heart failure with mid-range or mildly reduced ejection fraction
G Savarese, D Stolfo, G Sinagra, LH Lund - Nature Reviews Cardiology, 2022 - nature.com
Left ventricular ejection fraction (EF) remains the major parameter for diagnosis,
phenotyping, prognosis and treatment decisions in heart failure. The 2016 ESC heart failure …
phenotyping, prognosis and treatment decisions in heart failure. The 2016 ESC heart failure …
Challenges of sarcoidosis and its management
M Drent, ED Crouser, J Grunewald - New England Journal of …, 2021 - Mass Medical Soc
Sarcoidosis Sarcoidosis is a lung disease of unknown cause characterized by noncaseating
granulomas; the heart and nervous system may also be involved. It is often misdiagnosed; …
granulomas; the heart and nervous system may also be involved. It is often misdiagnosed; …
Cardiac sarcoidosis: phenotypes, diagnosis, treatment, and prognosis
J Lehtonen, V Uusitalo, P Pöyhönen… - European heart …, 2023 - academic.oup.com
Cardiac sarcoidosis (CS) results from epithelioid cell granulomas infiltrating the myocardium
and predisposing to conduction disturbances, ventricular tachyarrhythmias, and heart …
and predisposing to conduction disturbances, ventricular tachyarrhythmias, and heart …
Risk stratification of patients with cardiac sarcoidosis: the ILLUMINATE-CS registry
T Nabeta, T Kitai, Y Naruse, T Taniguchi… - European Heart …, 2022 - academic.oup.com
Aims This study evaluated the prognosis and prognostic factors of patients with cardiac
sarcoidosis (CS), an underdiagnosed disease. Methods and results Patients from a …
sarcoidosis (CS), an underdiagnosed disease. Methods and results Patients from a …
Heart failure subtypes and cardiomyopathies in women
EM DeFilippis, A Beale, T Martyn, A Agarwal… - Circulation …, 2022 - Am Heart Assoc
Heart failure affects over 2.6 million women and 3.4 million men in the United States with
known sex differences in epidemiology, management, response to treatment, and outcomes …
known sex differences in epidemiology, management, response to treatment, and outcomes …
Sarcoidosis-related cardiomyopathy: current knowledge, challenges, and future perspectives state-of-the-art review
NA Gilotra, JM Griffin, N Pavlovic, BA Houston… - Journal of cardiac …, 2022 - Elsevier
The prevalence of sarcoidosis-related cardiomyopathy is increasing. Sarcoidosis impacts
cardiac function through granulomatous infiltration of the heart, resulting in conduction …
cardiac function through granulomatous infiltration of the heart, resulting in conduction …
Cardiac magnetic resonance in giant cell myocarditis: a matched comparison with cardiac sarcoidosis
P Pöyhönen, HK Nordenswan… - European Heart …, 2023 - academic.oup.com
Aims Giant cell myocarditis (GCM) is an inflammatory cardiomyopathy akin to cardiac
sarcoidosis (CS). We decided to study the findings of GCM on cardiac magnetic resonance …
sarcoidosis (CS). We decided to study the findings of GCM on cardiac magnetic resonance …
Diagnostic approach for suspected acute myocarditis: considerations for standardization and broadening clinical spectrum
Myocarditis is most recognized in patients with moderate to severe, recent‐onset heart
failure. However, less typical presentations including myocardial infarction with normal …
failure. However, less typical presentations including myocardial infarction with normal …
Restrictive cardiomyopathy: definition and diagnosis
Restrictive cardiomyopathy (RCM) is a heterogeneous group of diseases characterized by
restrictive left ventricular pathophysiology, ie a rapid rise in ventricular pressure with only …
restrictive left ventricular pathophysiology, ie a rapid rise in ventricular pressure with only …